Pharmacolog announced that the currently appointed CEO Lars Gusch will step down from his position on April 30, 2024. This resignation is by mutual agreement with the Board of Directors, which in the meantime is working on the recruitment of a successor CEO, who will be announced in due course.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0902 SEK | -8.15% | +1.35% | +59.36% |
24/04 | Perpetua Medical AB Appoints Camilla Lonn as CFO | CI |
23/04 | Pharmacolog i Uppsala AB will Change its Ticker to PERP B from PHLOG B | CI |
1st Jan change | Capi. | |
---|---|---|
+59.36% | 983K | |
-13.12% | 18.53B | |
-40.05% | 2.82B | |
+23.79% | 1.91B | |
+1.29% | 1.65B | |
+28.27% | 1.25B | |
-14.61% | 988M | |
-20.31% | 910M | |
+2.50% | 786M | |
-24.78% | 634M |
- Stock Market
- Equities
- PERP B Stock
- News Pharmacolog i Uppsala AB
- Pharmacolog Announces Resignation of Lars Gusch as CEO, Effective from April 30, 2024